Shandong, China, April 29, 2025 — Wixbio announced the successful shipment of customized samples of inactivated duck eutheria (Reo) vaccine for the Vietnam market. The shipment includes 500 vials of the vaccine in 250ml size, which will be used for evaluation and testing purposes to meet the specific needs of customers in Vietnam.
Duck eutheria virus (Reo) is a pathogen that has a profound impact on the duck industry, causing growth retardation, reduced feed conversion, and high mortality. Therefore, an effective vaccine against this virus is essential to improve the efficiency and profitability of duck farming. Wixbio developed and produced this high-quality inactivated vaccine sample according to the specific requirements of Vietnamese customers.
To ensure the vaccine’s activity and potency during transportation, all samples were packed and shipped according to strict cold chain management standards. This not only ensures the vaccines’ safety but also demonstrates Wixbio’s stringent requirements for product quality control.
The shipment of inactivated duck eutheria (Reo) vaccine samples to Vietnam marks Wixbio’s further expansion of its international footprint and strengthens its relationship with Southeast Asian partners. Wixbio is committed to helping farmers worldwide meet disease challenges and promote healthy animal husbandry by providing adequate and safe animal health solutions.
About Wixbio:
Wixbio is a company specializing in the research, development, production, and marketing of veterinary drugs and animal vaccines. With advanced technology and high-quality products, the company provides strong support to the livestock industry worldwide. Wixbio always adheres to the customer’s needs as a guide and constantly promotes technological innovation, aiming to become a leading animal health partner worldwide.
